Abstract S2-02: The FERGI phase II study of the PI3K inhibitor pictilisib (GDC-0941) plus fulvestrant vs fulvestrant plus placebo in patients with ER+, aromatase inhibitor (AI)-resistant advanced or metastatic breast cancer – Part I results
| Image |  |
|---|---|
| Description | scientific article published in 2015 |
| Author/s |
author: Mika Derynck Susanne Vallentin Steven Gendreau Gallia Levy Eric Winer |
| Publication date | May 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |